Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock

Retrieved on: 2024-05-13 20:51:57

Tags for this article:

Stock market

Initial public offering

Prospectus

U.S. Securities and Exchange Commission

Shelf registration

Goldman Sachs

Forward-looking statement

Registration statement

Security

Kite Pharma

SOUTH SAN FRANCISCO

Allogene Therapeutics Inc.

Click the tags to see associated articles and topics

Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock. View article details on hiswai:

Excerpt

, May 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of ...

Article found on: ir.allogene.com

View Original Article